Two candidate genes (NAIP and SMN) have recently been reported for childhood onset spinal muscular atrophy (SMA). Although affected subjects show deletions of these genes, these deletions can lead to either a very mild or a severe phenotype. We have analysed a large number of clinically well defined patients, carriers, and normal controls to assess the frequency and extent of deletions encompassing both of these genes. A genotype analysis indicates that more extensive deletions are seen in the severe form of SMA than in the milder forms. In addition, 19% of phenotypically normal carriers are deleted for the NAIP gene; no carriers were deleted for the SMN gene. Our data suggest that deletions in both of these genes, using the currently available assays, are associated with both a severe and very mild phenotype.
Childhood onset proximal spinal muscular atrophy (SMA) is an autosomal recessive disease in which the integrity of the motor unit is disrupted leading to widespread and inappropriate death of alpha motor neurones in the spinal cord. Affected subjects have weakness, wasting, and areflexia with variable involvement of bulbar motor nuclei.' It is widely believed that muscular weakness and atrophy is secondary to this neurogenic process but there have been studies suggesting that muscle from these patients behaves abnormally in culture. 2 This disease is an important cause of morbidity and mortality in early life, with an incidence ofbetween 1 Genotype In analyses of multiply affected sibships including those with a difference in the clinical severity of the disease, the affected sibs had identical deletions when assayed using primers for exon 5 ofNAIP and exons 7 and 8 of SMN.
Discussion
This is an extensive analysis of the incidence of deletions in both SMN and NAIP genes in a large set of SMA patients and carriers. In the original papers, SMN gene deletions were found not to correlate with the severity of the phenotype whereas deletions in NAIP occurred more frequently in the more severely affected type I patients.'416 The data presented here suggest that there is a very strong correlation between the extent of the deletions and the severity of the disease.
The incidence of deletions which include both SMN and NAIP genes in SMA patients was much higher in type I patients compared to type II and III patients (63-6%, 8&8%, 12-2%, respectively). Patients suffering from the milder forms of the disease showed smaller deletions which predominantly included SMN but not NAIP. There is no statistically significant difference between deletions in types II and III suggesting that these two subtypes of SMA may represent a continuum. Consistent with this observation is the fact that families with two different phenotypes rarely include subjects with type I SMA. Furthermore, while the Finnish population might seem to contain a larger than expected number ofmixed phenotype families, these are the families for which we have the most accurate clinical data and it is therefore likely that the true incidence of mixed families is higher than reported here.
In two patients (type I and type II) who had deletions of SMN exon 7 and NAIP exon 5, but no deletion of SMN exon 8, it is possible that NAIP is proximal to SMN in accordance with the map published by Roy et al, '6 or that there are two deletion events. One type I patient is not deleted for SMN but deleted for NAIP, a genotype seen in 1-9% ofcarriers. This patient may possess other mutations in either SMN or other genes in the region. We are currently exploring this in detail. It is of note that deletions ofNAIP in carriers ofSMA occur almost exclusively in parents of type I patients. The detection ofNAIP deletions in carriers suggests that the non-mutated allele is probably deleted frequently. This also confirms the high degree of instability of this region. The patients who 
